
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1" specific-use="sps-1.9" article-type="letter" xml:lang="pt">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">MNHpJQpnjvSX6pkKCg37yTJ</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S0066-782X2022000400787</article-id>
      <article-id pub-id-type="publisher-id">abc.20210807</article-id>
      <article-id pub-id-type="doi">10.36660/abc.20210807</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Carta ao Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prevalência e Fatores Associados à SRAG por COVID-19 em Adultos e Idosos com Doença Cardiovascular Crônica: Uma Análise Crítica</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-5580-1049</contrib-id>
          <name>
            <surname>Ignácio</surname>
            <given-names>Fernanda Gunha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Fernanda Pinzon</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-5903-0026</contrib-id>
          <name>
            <surname>Baggio</surname>
            <given-names>Aline Oenning</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-7031-437X</contrib-id>
          <name>
            <surname>Marcon</surname>
            <given-names>Chaiana Esmeraldino Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label> 1 </label>
        <institution content-type="orgname">Universidade do Sul de Santa Catarina</institution>
        <addr-line>
          <named-content content-type="city">Tubarão</named-content>
          <named-content content-type="state">SC</named-content>
        </addr-line>
        <country country="BR">Brasil</country>
        <institution content-type="original"> Universidade do Sul de Santa Catarina, Tubarão, SC – Brasil </institution>
      </aff>
      <author-notes>
        <corresp id="c01">Correspondência: Fernanda Gunha Ignácio • Av. José Acácio Moreira, 787. CEP 88704-900, Tubarão, SC – Brasil E-mail: <email>fernandagunha@gmail.com</email> </corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>29</day>
        <month>04</month>
        <year>2022</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <month>04</month>
        <year>2022</year>
      </pub-date>
      <volume>118</volume>
      <issue>4</issue>
      <fpage>787</fpage>
      <lpage>788</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="pt">
        <kwd>COVID-19</kwd>
        <kwd>Coronavírus</kwd>
        <kwd>Pandemia</kwd>
        <kwd>Fatores de risco</kwd>
        <kwd>Doença Cardiovascular</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="11"/>
        <page-count count="2"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>Caro Editor,</bold>
    </p>
    <p>O estudo de Paiva et al. avaliou a incidência de pacientes infectados pelo vírus COVID-19, associado a doenças cardiovasculares (DCV), no Brasil. No estudo, conclui- se que a alta prevalência de síndrome respiratória aguda grave (SRAG) em adultos e idosos relaciona-se com características sociodemográficas, clínicas, sinais e sintomas. Visto isso, reitera-se a importância da atenção primária à saúde – a fim da manutenção das consultas periódicas, visando controle da doença e sintomatologia, ao passo que a presença de comorbidades cardiovasculares aumenta em casos severos de COVID-19. <sup><xref rid="B1" ref-type="bibr">1</xref></sup> </p>
    <p>No estudo, a população estudada foi de 116.343 pacientes, dos quais 61,9% foram diagnosticados por SRAG causada por COVID-19. Ao mesmo tempo, o estudo demonstra que a presença de doenças crônicas pode ser considerada fator de risco à infecção por COVID-19, devido a maiores vulnerabilidade e morbimortalidade. Sendo assim, pacientes com DCV prévia são mais predisponentes a desenvolverem quadros mais graves. Entretanto, no sexo feminino, observou-se uma menor prevalência de SRAG por COVID-19 devido ao fato de haver variação entre a resposta imunológica e a susceptibilidade a infecções virais entre os sexos, o que gera, assim, diferenças na gravidade e evolução da doença. <sup><xref rid="B1" ref-type="bibr">1</xref></sup> </p>
    <p>Em Wuhan, na China, uma metanálise com 46.248 pacientes infectados analisou as comorbidades mais prevalentes, estando a DCV (5±4%) em terceiro lugar. Foram avaliados, por Wang e colaboradores, 2020, somente pacientes hospitalizados acometidos pela infecção viral, os quais apresentaram maior prevalência – 19,6% – de DCV, um dado reforça o fato de que a comorbidade DCV contribui para o agravo da gravidade da COVID-19, visto a evidente necessidade de internação. Além disso, os pacientes demonstraram evolução com maior hipoxemia e imprescindível internação em UTIs. <sup><xref rid="B2" ref-type="bibr">2</xref></sup> O estudo realizado por Melo evidenciou resultados semelhantes a achados de um estudo na Itália – ambos analisados no decorrer de sete dias no mês de março de 2020; constatou-se decréscimo de 13% de pacientes com infarto agudo do miocárdio (IAM) quando associados na mesma semana do ano de 2019. Por outro lado, mesmo ocorrendo uma redução de casos de IAM e da taxa de números de óbitos hospitalares, houve um aumento na taxa de letalidade intra-hospitalar nas internações por DCV. Ambos os estudos demonstraram a relação da COVID-19 com a alta taxa de prevalência de lesões cardíacas e um grande potencial de gravidade da COVID-19 nas DCV, em que a letalidade em pacientes internados com DCV alcançou parcela mais economicamente ativa da população – de 20 a 59 anos. <sup><xref rid="B3" ref-type="bibr">3</xref></sup> </p>
    <p>Visto isso, destaca-se a importância do acompanhamento médico a pacientes portadores de doenças crônicas, já que, segundo Askin et al., no ano de 2020, houve aumento acentuado no dano do miocárdio de pacientes com COVID-19, aumentando o risco de morbimortalidade. Dessa forma, a valorização da DCV como complicação associada ao vírus COVID-19, devido ao agravamento da sintomatologia da doença, é de extrema significância para a atenção básica à saúde. <sup><xref rid="B4" ref-type="bibr">4</xref></sup> </p>
    <p>A presente situação exige estratégias que visem a prevenção de complicações associadas a doenças crônicas, como DCV. Portanto, os dados atuais demonstram a necessidade de atenção especial aos pacientes do grupo de risco assim como um manejo adequado das complicações cardiovasculares, visando uma rápida identificação e aplicação de tratamento adequado. Ademais, recomenda-se aos portadores de DCV a atualização das vacinas devido ao risco de infecção bacteriana secundária pelo SARS-CoV-2, assim como a adesão à dieta adequada, sono regular e atividade física, evitando o tabagismo e etilismo. <sup><xref rid="B2" ref-type="bibr">2</xref></sup> </p>
  </body>
  <back>
    <ref-list>
      <title>Referências</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation>1. Paiva KM, Hillesheim D, Rech CR, Delevatti RS, Brown RVS, Gonzáles AI, et al. Prevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease. Arq Bras Cardiol. 2021; 117 (5): 968 - 75. doi: 10.36660/abc.20200955. </mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paiva</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Hillesheim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rech</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Delevatti</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>RVS</given-names>
            </name>
            <name>
              <surname>Gonzáles</surname>
              <given-names>AI</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Prevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2021</year>
          <volume>117</volume>
          <issue>5</issue>
          <fpage>968</fpage>
          <lpage>975</lpage>
          <issue-id pub-id-type="doi">10.36660/abc.20200955.</issue-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation>2. Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AE, Santos KAQ, Machado TIV, et al. The Heart and COVID-19: What Cardiologists Need to Know. Arq Bras Cardiol. 2020 ; 114 (5): 805 - 16. doi: 10.36660/abc.20200279. </mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costa</surname>
              <given-names>IBSDS</given-names>
            </name>
            <name>
              <surname>Bittar</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Rizk</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Araújo</surname>
              <given-names>AE</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>KAQ</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>TIV</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The Heart and COVID-19: What Cardiologists Need to Know</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <volume>114</volume>
          <issue>5</issue>
          <fpage>805</fpage>
          <lpage>816</lpage>
          <issue-id pub-id-type="doi">10.36660/abc.20200279.</issue-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation>3. Normando PG, Araújo Filho JA, Fonseca GA, Rodrigues REF, Oliveira VA, Hajjar LA, et al. Reduction in Hospitalization and Increase in Mortality Due to Cardiovascular Diseases during the COVID-19 Pandemic in Brazil. Arq Bras Cardiol. 2021; 116 (3): 371 - 80. doi: 10.36660/abc.20200821. </mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Normando</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Araújo</surname>
              <given-names>JA</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Fonseca</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>REF</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Hajjar</surname>
              <given-names>LA</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Reduction in Hospitalization and Increase in Mortality Due to Cardiovascular Diseases during the COVID-19 Pandemic in Brazil</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2021</year>
          <volume>116</volume>
          <issue>3</issue>
          <fpage>371</fpage>
          <lpage>380</lpage>
          <issue-id pub-id-type="doi">10.36660/abc.20200821.</issue-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation>4. Askin L, Tanrıverdi O, Askin HS. The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases. Arq Bras Cardiol. 2020; 114 (5): 817 - 22. doi: 10.36660/abc.20200273. </mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Askin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tanrıverdi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Askin</surname>
              <given-names>HS</given-names>
            </name>
          </person-group>
          <article-title>The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <volume>114</volume>
          <issue>5</issue>
          <fpage>817</fpage>
          <lpage>822</lpage>
          <issue-id pub-id-type="doi">10.36660/abc.20200273.</issue-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="reply" id="s1" xml:lang="pt">
    <front-stub>
      <title-group>
        <article-title>Carta-resposta</article-title>
      </title-group>
    </front-stub>
    <body>
      <p>Agradecemos aos autores pela análise submetida “Prevalência e Fatores Associados à SRAG por COVID-19 em Adultos e Idosos com Doença Cardiovascular Crônica: Uma Análise Crítica”, em especial pela exposição de dados que reforçam os achados apresentados em nosso estudo. <sup><xref rid="B1" ref-type="bibr">1</xref></sup> Destaca-se também a relevância da análise em relação ao aumento das taxas de letalidade intra-hospitalar nas internações por doenças cardiovasculares (DCV) como fator potencializador da necessidade de valorização deste grupo de risco na análise das complicações associadas à COVID-19. <sup><xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref></sup> </p>
      <p>As DCV já são estabelecidas como marcadores de risco na atenção primária à saúde (APS) brasileira, com o intuito de garantir a longitudinalidade do cuidado ao usuário e o desenvolvimento de estratégias preventivas voltadas ao cuidado integral da comunidade, <sup><xref rid="B4" ref-type="bibr">4</xref></sup> porém é essencial o questionamento quanto à aplicabilidade destas ações na estratégia de saúde da família (ESF). O desafio do monitoramento ao usuário como forma de gestão às DCV sugere ultrapassar o imperativo das ações que apoiam o sistema diagnóstico e terapêutico no cuidado e manejo às condições crônicas. <sup><xref rid="B5" ref-type="bibr">5</xref></sup> Neste sentido, um estudo publicado recentemente, com mais de 100 milhões de participantes de todo o mundo, destaca a importância da prevenção, da detecção e do controle na atenção primária, inclusive em países de baixa e média renda, com propostas de ações como uso de mensagens de texto para acompanhar os usuários com fatores de risco. <sup><xref rid="B6" ref-type="bibr">6</xref></sup> </p>
      <p>No contexto atual de enfrentamento à pandemia da COVID-19, esta discussão torna-se ainda mais relevante, pois, conforme reforçado pelos autores que realizaram a análise crítica, o agravamento da sintomatologia da COVID-19 coloca as DCV como um fator de risco importante às ações de rastreio, manejo e intervenção precoce.</p>
      <p>Estudos sugerem a criação de propostas de modelos de cuidados às condições crônicas, como as DCV, envolvendo formação de grupos focais, que obtiveram resultados positivos na adesão da comunidade, melhora de indicadores clínicos durante o acompanhamento, adoção de prática de autocuidado e melhor análise das prioridades no planejamento em saúde. <sup><xref rid="B6" ref-type="bibr">6</xref></sup> De forma similar, a Organização Mundial de Saúde (OMS) lançou um guia de implementação para gestão de DCV na atenção primária, com propostas de triagem, avaliação e manejo de riscos neste nível de atenção e educação em saúde para profissionais quanto ao rastreio de fatores de risco, intervenções no estilo de vida e encaminhamentos necessários. <sup><xref rid="B7" ref-type="bibr">7</xref></sup> Especialmente acerca do manejo em usuários com DCV e sintomas persistentes pós-COVID-19, a complexidade clínica e psicossocial proporcionada pela coexistência dessas condições implica a necessidade de um cuidado multiprofissional e de longo prazo. Finalizamos, assim, agradecendo à possibilidade de reforçar a necessidade de se rever as ações na atenção primária à saúde, em especial em nosso atual contexto de saúde.</p>
    </body>
    <back>
      <ref-list>
        <title>Referências</title>
        <ref id="B5">
          <label>1</label>
          <mixed-citation>1. Paiva KM, Hillesheim D, Rech CR, Delevatti RS, Brown RVS, Gonzáles AI, et al. Prevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease. Arq Bras Cardiol. 2021; 117 (5): 968 - 75. doi: 10.36660/abc.20200955. </mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Paiva</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Hillesheim</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rech</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Delevatti</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RVS</given-names>
              </name>
              <name>
                <surname>Gonzáles</surname>
                <given-names>AI</given-names>
              </name>
              <etal>et al</etal>
            </person-group>
            <article-title>Prevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease</article-title>
            <source>Arq Bras Cardiol</source>
            <year>2021</year>
            <volume>117</volume>
            <issue>5</issue>
            <fpage>968</fpage>
            <lpage>975</lpage>
            <issue-id pub-id-type="doi">10.36660/abc.20200955.</issue-id>
          </element-citation>
        </ref>
        <ref id="B6">
          <label>2</label>
          <mixed-citation>2. Zhang J, Lu S, Wang X, Jia X, Li J, Lei H, et al. Do Underlying Cardiovascular Diseases Have any Impact on Hospitalised Patients with COVID-19? Heart. 2020; 106 (15): 1148 - 53. doi: 10.1136/heartjnl-2020-316909. </mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>H</given-names>
              </name>
              <etal>et al</etal>
            </person-group>
            <article-title>Do Underlying Cardiovascular Diseases Have any Impact on Hospitalised Patients with COVID-19?</article-title>
            <source>Heart</source>
            <year>2020</year>
            <volume>106</volume>
            <issue>15</issue>
            <fpage>1148</fpage>
            <lpage>1153</lpage>
            <issue-id pub-id-type="doi">10.1136/heartjnl-2020-316909.</issue-id>
          </element-citation>
        </ref>
        <ref id="B7">
          <label>3</label>
          <mixed-citation>3. Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, et al. Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-Analysis. Am J Emerg Med. 2021; 46 : 382 - 91. doi: 10.1016/j.ajem.2020.10.022. </mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Hessami</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shamshirian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Heydari</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pourali</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Alizadeh-Navaei</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moosazadeh</surname>
                <given-names>M</given-names>
              </name>
              <etal>et al</etal>
            </person-group>
            <article-title>Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-Analysis</article-title>
            <source>Am J Emerg Med</source>
            <year>2021</year>
            <volume>46</volume>
            <fpage>382</fpage>
            <lpage>391</lpage>
            <issue-id pub-id-type="doi">10.1016/j.ajem.2020.10.022.</issue-id>
          </element-citation>
        </ref>
        <ref id="B8">
          <label>4</label>
          <mixed-citation>4. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Prevenção Clínica de Doenças Cardiovasculares, Cerebrovasculares e Renais. Brasília, DF : Ministério da Saúde; 2006 .</mixed-citation>
          <element-citation publication-type="report">
            <person-group person-group-type="author">
              <collab>Brasil</collab>
              <collab>Ministério da Saúde</collab>
              <collab>Secretaria de Atenção à Saúde</collab>
              <collab>Departamento de Atenção Básica</collab>
            </person-group>
            <source>Prevenção Clínica de Doenças Cardiovasculares, Cerebrovasculares e Renais</source>
            <publisher-loc>Brasília, DF</publisher-loc>
            <publisher-name>Ministério da Saúde</publisher-name>
            <year>2006</year>
          </element-citation>
        </ref>
        <ref id="B9">
          <label>5</label>
          <mixed-citation>5. Silva PM, Lima MJ, Neves PM, Macedo ME. Prevalence of Cardiovascular Risk Factors and Other Comorbidities in Patients with Hypertension in Portuguese Primary Health Care Populations: The PRECISE Study. Rev Port Cardiol. 2019; 38 (6): 427 - 437. doi: 10.1016/j.repc.2018.09.011 </mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Silva</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Neves</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Macedo</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Cardiovascular Risk Factors and Other Comorbidities in Patients with Hypertension in Portuguese Primary Health Care Populations: The PRECISE Study</article-title>
            <source>Rev Port Cardiol</source>
            <year>2019</year>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>427</fpage>
            <lpage>437</lpage>
            <issue-id pub-id-type="doi">10.1016/j.repc.2018.09.011</issue-id>
          </element-citation>
        </ref>
        <ref id="B10">
          <label>6</label>
          <mixed-citation>6. NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies with 104 Million Participants . Lancet. 2021; 398 (10304): 957 - 80. doi: 10.1016/S0140-6736(21)01330-1. </mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <collab>NCD Risk Factor Collaboration (NCD-RisC)</collab>
            </person-group>
            <article-title>Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies with 104 Million Participants</article-title>
            <source>Lancet</source>
            <year>2021</year>
            <volume>398</volume>
            <issue>10304</issue>
            <fpage>957</fpage>
            <lpage>980</lpage>
            <issue-id pub-id-type="doi">10.1016/S0140-6736(21)01330-1.</issue-id>
          </element-citation>
        </ref>
        <ref id="B11">
          <label>7</label>
          <mixed-citation>7. Yeoh EK, Wong MCS, Wong ELY, Yam C, Poon CM, Chung RY, et al. Benefits and Limitations of Implementing Chronic Care Model (CCM) in Primary Care Programs: A Systematic Review. Int J Cardiol. 2018; 258 : 279 - 88. doi: 10.1016/j.ijcard.2017.11.057. </mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <name>
                <surname>Yeoh</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>MCS</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>ELY</given-names>
              </name>
              <name>
                <surname>Yam</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Poon</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>RY</given-names>
              </name>
              <etal>et al</etal>
            </person-group>
            <article-title>Benefits and Limitations of Implementing Chronic Care Model (CCM) in Primary Care Programs: A Systematic Review</article-title>
            <source>Int J Cardiol</source>
            <year>2018</year>
            <volume>258</volume>
            <fpage>279</fpage>
            <lpage>288</lpage>
            <issue-id pub-id-type="doi">10.1016/j.ijcard.2017.11.057.</issue-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prevalence and Associated Factors of SARS caused by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease: A Critical Analysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-5580-1049</contrib-id>
          <name>
            <surname>Ignácio</surname>
            <given-names>Fernanda Gunha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Fernanda Pinzon</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-5903-0026</contrib-id>
          <name>
            <surname>Baggio</surname>
            <given-names>Aline Oenning</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0000-0001-7031-437X</contrib-id>
          <name>
            <surname>Marcon</surname>
            <given-names>Chaiana Esmeraldino Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1001">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1001">
        <label> 1 </label>
        <country country="BR">Brazil</country>
        <institution content-type="original"> Universidade do Sul de Santa Catarina, Tubarão, SC – Brazil </institution>
      </aff>
      <author-notes>
        <corresp id="c01001">Mailing Address: Fernanda Gunha Ignácio • Av. José Acácio Moreira, 787. Postal Code 88704-900, Tubarão, SC – Brazil E-mail: fernandagunha@gmail.com</corresp>
      </author-notes>
      <kwd-group xml:lang="en">
        <kwd>COVID-19</kwd>
        <kwd>Coronavirus</kwd>
        <kwd>Pandemic</kwd>
        <kwd>Risk factors</kwd>
        <kwd>Cardiovascular disease</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>Dear Editor,</bold>
      </p>
      <p>The study by Paiva et al. evaluated the incidence of patients infected with the COVID-19 virus, associated with cardiovascular diseases (CVD), in Brazil. It is concluded that the high prevalence of severe acute respiratory syndrome (SARS) in adults and in the elderly is related to sociodemographic and clinical characteristics, signs and symptoms. In view of that, the importance of primary health care is reiterated – in order to maintain regular medical visits aiming at controlling the disease and symptoms, while the presence of cardiovascular comorbidities increases in severe COVID-19 cases. <sup><xref rid="B5" ref-type="bibr">1</xref></sup> </p>
      <p>The study included 116,343 patients, of whom 61.9% were diagnosed with SARS caused by COVID-19. At the same time, the study demonstrates that the presence of chronic diseases can be considered a risk factor for infection by COVID-19 due to greater vulnerability and morbimortality. Therefore, patients with previous CVD are more likely to develop more severe conditions. However, in females, there was a lower prevalence of SARS by COVID-19 because there is a variation between the immune response and the susceptibility to viral infections between sexes, which generates differences in disease severity and evolution. <sup><xref rid="B5" ref-type="bibr">1</xref></sup> </p>
      <p>In Wuhan, China, a meta-analysis with 46,248 infected patients analyzed the most prevalent comorbidities, with CVD (5±4%) in third place. Wang et al., 2020 evaluated only hospitalized patients affected by viral infection, which has shown a higher prevalence – 19.6% – CVD, which reinforces the fact that the comorbidity of CVD contributes an increased severity of COVID-19, given the evident need for hospitalization. In addition, the patients evolved with higher levels of hypoxemia and urgent hospitalization in ICUs. <sup><xref rid="B6" ref-type="bibr">2</xref></sup> In the study conducted by Melo, the results were</p>
      <p>similar to those found in a study in Italy – both analyzed over seven days in March 2020; it found a decrease of 13% of patients with acute myocardial infarction (AMI) associated in the same week of 2019. On the other hand, even though there was a reduction in AMI cases and in the rate of hospital deaths, there was an increase in the in-hospital lethality rate in hospitalizations for CVD. Both studies demonstrated the relationship of COVID-19 with the high prevalence of cardiac lesions and a great potential for COVID-19 severity in CVD, in which mortality of hospitalized patients with CVD reached the most economically active portion of the population – from 20 to 59 years of age. <sup><xref rid="B7" ref-type="bibr">3</xref></sup> </p>
      <p>In view of that, the importance of medical follow-up of patients with chronic diseases is highlighted, since, according to Askin et al., in 2020, there was a marked increase in myocardial damage in patients with COVID-19, increasing the risk of morbimortality. Therefore, the appreciation of CVD as a complication associated with the COVID-19 virus, due to the increase of the disease symptoms, is of extreme significance for primary health care. <sup><xref rid="B8" ref-type="bibr">4</xref></sup> </p>
      <p>The current situation requires strategies aimed at preventing complications associated with chronic diseases, such as CVD. Therefore, current data demonstrate the need for special attention to patients at high risk as well as proper management of cardiovascular complications, aiming at quickly identifying and applying adequate treatment. Furthermore, it is recommended that patients with CVD get vaccinated – due to the risk of secondary bacterial infection by SARS-CoV-2 – and adopt a proper diet, regular sleep and physical activity, avoiding smoking and alcohol consumption.</p>
    </body>
    <sub-article article-type="reply" id="s2" xml:lang="pt">
      <front-stub>
        <title-group>
          <article-title>Reply</article-title>
        </title-group>
      </front-stub>
      <body>
        <p>We would like to thank the authors for the analysis “Prevalence and Factors Associated with SARS caused by COVID-19 in Adults and Aged People with Chronic Cardiovascular Disease: A Critical Analysis”, especially due to the exposure of data reinforcing the findings presented in our study. <sup><xref rid="B50" ref-type="bibr">1</xref></sup> The analysis is also relevant because it includes information regarding the increase of in-hospital mortality rates in hospitalizations due to cardiovascular diseases (CVD) as a factor that further calls for the need to draw special attention to this group at risk in the analysis of complications associated with COVID-19. <sup><xref rid="B60" ref-type="bibr">2</xref>, <xref rid="B70" ref-type="bibr">3</xref></sup> </p>
        <p>CVDs are established as risk markers in the Brazilian primary health care (PHC) in order to guarantee the longitudinality of user care and the development of preventive strategies aimed at the integral care of the community, <sup><xref rid="B80" ref-type="bibr">4</xref></sup> but it is essential to question the applicability of these actions in the family health strategy (FHS). The challenge of monitoring the users as a way of managing CVD suggests overcoming the imperative of actions that support the diagnostic and therapeutic system in the care and management of chronic conditions. <sup><xref rid="B90" ref-type="bibr">5</xref></sup> A recently published study with more than 100 million participants from around the world highlights the importance of prevention, detection and control in primary care, including in low- and middle-income countries, with proposals for actions that include sending text messages to check on users with risk factors. <sup><xref rid="B100" ref-type="bibr">6</xref></sup> </p>
        <p>In the current context of facing the COVID-19 pandemic, this discussion is even more relevant because, as emphasized by the authors who conducted the critical analysis, the worsening of the symptoms of COVID-19 places CVDs as an important risk factor that affect screening, management and early intervention actions.</p>
        <p>Studies suggest the creation of proposals for models of care for chronic conditions, such as CVD, involving focus groups with positive results in the community, improvement of clinical indicators during follow-up, adoption of self-care practices and better analysis of the priorities in health planning. <sup><xref rid="B100" ref-type="bibr">6</xref></sup> Similarly, the World Health Organization (WHO) released an implementation guide for CVD management in primary care, with proposals for risk screening, assessment and management at this level of health care and education for professionals regarding the screening of risk factors, lifestyle interventions and the required referrals. <sup><xref rid="B110" ref-type="bibr">7</xref></sup> Especially regarding the management of users with CVD and persistent symptoms after COVID-19, the clinical and psychosocial complexity provided by the coexistence of these conditions calls for long-term multidisciplinary care. To conclude, we would like to express our gratitude for the possibility of reinforcing the need to review primary health care actions, especially in our current health context.</p>
      </body>
      <back>
        <ref-list>
          <title>References</title>
          <ref id="B50">
            <label>1</label>
            <mixed-citation>1. Paiva KM, Hillesheim D, Rech CR, Delevatti RS, Brown RVS, Gonzáles AI, et al. Prevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease. Arq Bras Cardiol. 2021; 117 ( 5): 968 - 75. doi: 10.36660/abc.20200955.</mixed-citation>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Paiva</surname>
                  <given-names>KM</given-names>
                </name>
                <name>
                  <surname>Hillesheim</surname>
                  <given-names>D</given-names>
                </name>
                <name>
                  <surname>Rech</surname>
                  <given-names>CR</given-names>
                </name>
                <name>
                  <surname>Delevatti</surname>
                  <given-names>RS</given-names>
                </name>
                <name>
                  <surname>Brown</surname>
                  <given-names>RVS</given-names>
                </name>
                <name>
                  <surname>Gonzáles</surname>
                  <given-names>AI</given-names>
                </name>
                <etal>et al</etal>
              </person-group>
              <article-title>Prevalence and Associated Factors of SARS by Covid-19 in Adults and Aged People with Chronic Cardiovascular Disease</article-title>
              <source> Arq Bras Cardiol </source>
              <year>2021</year>
              <volume>117</volume>
              <issue>5</issue>
              <fpage>968</fpage>
              <lpage>975</lpage>
              <issue-id pub-id-type="doi">10.36660/abc.20200955.</issue-id>
            </element-citation>
          </ref>
          <ref id="B60">
            <label>2</label>
            <mixed-citation>2. Zhang J, Lu S, Wang X, Jia X, Li J, Lei H, et al. Do Underlying Cardiovascular Diseases Have any Impact on Hospitalised Patients with COVID-19? Heart . 2020; 106 (15): 1148 - 53. doi: 10.1136/heartjnl-2020-316909.</mixed-citation>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Zhang</surname>
                  <given-names>J</given-names>
                </name>
                <name>
                  <surname>Lu</surname>
                  <given-names>S</given-names>
                </name>
                <name>
                  <surname>Wang</surname>
                  <given-names>X</given-names>
                </name>
                <name>
                  <surname>Jia</surname>
                  <given-names>X</given-names>
                </name>
                <name>
                  <surname>Li</surname>
                  <given-names>J</given-names>
                </name>
                <name>
                  <surname>Lei</surname>
                  <given-names>H</given-names>
                </name>
                <etal>et al</etal>
              </person-group>
              <article-title>Do Underlying Cardiovascular Diseases Have any Impact on Hospitalised Patients with COVID-19?</article-title>
              <source> Heart </source>
              <year>2020</year>
              <volume>106</volume>
              <issue>15</issue>
              <fpage>1148</fpage>
              <lpage>1153</lpage>
              <issue-id pub-id-type="doi">10.1136/heartjnl-2020-316909.</issue-id>
            </element-citation>
          </ref>
          <ref id="B70">
            <label>3</label>
            <mixed-citation>3. Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, et al. Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-Analysis. Am J Emerg Med. 2021; 46 : 382 - 91. doi: 10.1016/j.ajem.2020.10.022.</mixed-citation>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Hessami</surname>
                  <given-names>A</given-names>
                </name>
                <name>
                  <surname>Shamshirian</surname>
                  <given-names>A</given-names>
                </name>
                <name>
                  <surname>Heydari</surname>
                  <given-names>K</given-names>
                </name>
                <name>
                  <surname>Pourali</surname>
                  <given-names>F</given-names>
                </name>
                <name>
                  <surname>Alizadeh-Navaei</surname>
                  <given-names>R</given-names>
                </name>
                <name>
                  <surname>Moosazadeh</surname>
                  <given-names>M</given-names>
                </name>
                <etal>et al</etal>
              </person-group>
              <article-title>Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-Analysis</article-title>
              <source> Am J Emerg Med </source>
              <year>2021</year>
              <volume>46</volume>
              <fpage>382</fpage>
              <lpage>391</lpage>
              <issue-id pub-id-type="doi">10.1016/j.ajem.2020.10.022.</issue-id>
            </element-citation>
          </ref>
          <ref id="B80">
            <label>4</label>
            <mixed-citation>4. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Prevenção Clínica de Doenças Cardiovasculares, Cerebrovasculares e Renais. Brasília, DF : Ministério da Saúde; 2006 .</mixed-citation>
            <element-citation publication-type="report">
              <person-group person-group-type="author">
                <collab>Brasil</collab>
                <collab>Ministério da Saúde</collab>
                <collab>Secretaria de Atenção à Saúde</collab>
                <collab>Departamento de Atenção Básica</collab>
              </person-group>
              <source> Prevenção Clínica de Doenças Cardiovasculares, Cerebrovasculares e Renais </source>
              <publisher-loc>Brasília, DF</publisher-loc>
              <publisher-name>Ministério da Saúde</publisher-name>
              <year>2006</year>
            </element-citation>
          </ref>
          <ref id="B90">
            <label>5</label>
            <mixed-citation>5. Silva PM, Lima MJ, Neves PM, Macedo ME. Prevalence of Cardiovascular Risk Factors and Other Comorbidities in Patients with Hypertension in Portuguese Primary Health Care Populations: The PRECISE Study. Rev Port Cardiol. 2019; 38 (6): 427 - 437. doi: 10.1016/j.repc.2018.09.011</mixed-citation>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Silva</surname>
                  <given-names>PM</given-names>
                </name>
                <name>
                  <surname>Lima</surname>
                  <given-names>MJ</given-names>
                </name>
                <name>
                  <surname>Neves</surname>
                  <given-names>PM</given-names>
                </name>
                <name>
                  <surname>Macedo</surname>
                  <given-names>ME</given-names>
                </name>
              </person-group>
              <article-title>Prevalence of Cardiovascular Risk Factors and Other Comorbidities in Patients with Hypertension in Portuguese Primary Health Care Populations: The PRECISE Study</article-title>
              <source> Rev Port Cardiol </source>
              <year>2019</year>
              <volume>38</volume>
              <issue>6</issue>
              <fpage>427</fpage>
              <lpage>437</lpage>
              <issue-id pub-id-type="doi">10.1016/j.repc.2018.09.011</issue-id>
            </element-citation>
          </ref>
          <ref id="B100">
            <label>6</label>
            <mixed-citation>6. NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies with 104 Million Participants. Lancet. 2021; 398 (10304): 957 - 80. doi: 10.1016/S0140-6736(21)01330-1.</mixed-citation>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <collab>NCD Risk Factor Collaboration (NCD-RisC)</collab>
              </person-group>
              <article-title>Worldwide Trends in Hypertension Prevalence and Progress in Treatment and Control from 1990 to 2019: A Pooled Analysis of 1201 Population-Representative Studies with 104 Million Participants</article-title>
              <source> Lancet </source>
              <year>2021</year>
              <volume>398</volume>
              <issue>10304</issue>
              <fpage>957</fpage>
              <lpage>980</lpage>
              <issue-id pub-id-type="doi">10.1016/S0140-6736(21)01330-1.</issue-id>
            </element-citation>
          </ref>
          <ref id="B110">
            <label>7</label>
            <mixed-citation>7. Yeoh EK, Wong MCS, Wong ELY, Yam C, Poon CM, Chung RY, et al. Benefits and Limitations of Implementing Chronic Care Model (CCM) in Primary Care Programs: A Systematic Review. Int J Cardiol. 2018; 258 : 279 - 88. doi: 10.1016/j.ijcard.2017.11.057.</mixed-citation>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Yeoh</surname>
                  <given-names>EK</given-names>
                </name>
                <name>
                  <surname>Wong</surname>
                  <given-names>MCS</given-names>
                </name>
                <name>
                  <surname>Wong</surname>
                  <given-names>ELY</given-names>
                </name>
                <name>
                  <surname>Yam</surname>
                  <given-names>C</given-names>
                </name>
                <name>
                  <surname>Poon</surname>
                  <given-names>CM</given-names>
                </name>
                <name>
                  <surname>Chung</surname>
                  <given-names>RY</given-names>
                </name>
                <etal>et al</etal>
              </person-group>
              <article-title>Benefits and Limitations of Implementing Chronic Care Model (CCM) in Primary Care Programs: A Systematic Review</article-title>
              <source> Int J Cardiol </source>
              <year>2018</year>
              <volume>258</volume>
              <fpage>279</fpage>
              <lpage>288</lpage>
              <issue-id pub-id-type="doi">10.1016/j.ijcard.2017.11.057.</issue-id>
            </element-citation>
          </ref>
        </ref-list>
      </back>
    </sub-article>
  </sub-article>
</article>